MedPath
HSA Approval

UBISTESIN INJECTION

SIN05504P

UBISTESIN INJECTION

UBISTESIN INJECTION

February 26, 1991

3M TECHNOLOGIES (S) PTE. LTD.

3M TECHNOLOGIES (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

Registrant3M TECHNOLOGIES (S) PTE. LTD.
Licence Holder3M TECHNOLOGIES (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

SUBMUCOSAL

Medical Information

N01BB58

articaine, combinations

Manufacturer Information

3 m technologies (s) pte. ltd.

3M Deutschland GmbH

Active Ingredients

EPINEPHRINE HCl EQV EPINEPHRINE

0.005 mg/ml

Epinephrine

ARTICAINE HCl

40 mg/ml

Articaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

UBISTESIN INJECTION - HSA Approval | MedPath